In vitro antibacterial activity of BL-S640 was compared to that of cephalothin and cephalexin against Gram-negative and Gram-positive bacteria isolated from clinical specimens. BL-S640 demonstrated the best activity on nearly all microbial species studied, except for Haemophilus influenzae and Diplococcus pneumoniae against which cephalothin was slightly more active.
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BL-S640 (a7-(2-aryl-2-aminoacetamido)-3-(heterocyclicthiomethyl)
cephalosporin) (Bristol) is a new broad-sepctrum semi-synthetic cephalosporin, which is water-soluble and well absorbed by man1) and animals after oral administration2).
The present study reports the comparative minimal inhibitory concentrations (MIC) for BL-S640, cephalothin (considered as the leading cephalosporin) and cephalexin (considered as the most representative of the oral cephalosporins) against strains isolated in human pathology.
Material and Methods

Microbial strains
The 99 bacteria studied were recently isolated from clinical specimens (urine, blood, pus, sputum, etc.) collected at the Hepital Universitaire Brugmann, Brussels. Included in the survey were 13 strains each of Salmonella, Proteus, Klebsiella, Escherichia coli, H. influenzae, 8 strains of Listeria monocytogenes, 13 strains of Streptococcus faecalis and 13 strains of D. pneumoniae.
Antibiotic sensitivity testing MIC were determined by an agar dilution technique, on MUELLER-HINTON Agar BBL, to which were added, in the case of D. pneumoniae, Haemophilus and St. faecalis, 3 ug per ml of factor V (nicotinamide-adenine dinucleotide phosphate-BDH Chemicals Ltd.) and 2% defibrinated horse blood. Serial twofold dilutions of the antibiotics (BL-S640, powder for analysis, Bristol; cephalothin and cephalexin, Lilly) were prepared, starting from initial concentrations of 100 pg per ml. Overnight MUELLER-HINTON broth cultures were diluted to contain 10 5 organisms per ml for E. coli, Klebsiella, Listeria, Proteus and Salmonella. D. pneumoniae, Haemophilus and St. faecalis were grown in the same medium supplemented with 0.5% defibrinated horse blood in a 5 % CO2-enriched atomsphere, and diluted to contain 10 6 organisms per ml. These inocula were spotted with an automatic multipoint inoculator onto the surface of the agar plates'). D.
pneumoniae and Haemophilus were incubated in a 5 % CO2 -enriched atmosphere.
Results were read after overnight incubation at 37°C. The MIC was designated as the lowest antibiotic concentration yielding no colony at the site of inoculation.
Disk diffusion tests were performed according to the method described by BAUER et al.4) using the same media as in the MIC determination, and disks containing 30 leg of cephalothin, cephalexin or BL-S640.
Inhibition zones were measured with a caliper after overnight incubation at 37°C. Table 1 , those for Gram-positive bacteria in Table 2 .
Although there sometimes exist considerable differences between susceptibility of one strain (Fig. 1a) , cephalothin ( Fig. 1b) BL-S640 could be a valuable drug among the oral cephalosporins: it has been shown (in animal experiments) that peak blood concentrations of this drug are similar to those obtained with cephalexin when administered at the same oral doses2), but blood levels are more prolonged.
Moreover, volume of tissue distribution of this drug increases as dosage increases 1). Clinical efficacy in man, as well as toxicity and side-effects of BL-S640 must be further investigated.
